A recent study found that strict adherence to high-throughput sequencing (HTS) technology-based carrier screening in pre-conceptional or early pregnancy stage, along with complete follow-up and retesting, can achieve high efficiency in the prevention of severe thalassemia birth defects.
This article was originally published on MedicalXpress.com